Skip to content

Clinical trials

Phase 3 Asthma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 3 Country / region: Australia Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20072
20082
20101
20111
20124
20134
20146
20154
20164
20174
20182
20192
20212
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline16
AstraZeneca11
Boehringer Ingelheim4
Sanofi4
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Teva Branded Pharmaceutical Products R&D, Inc.2
Generate Biomedicines1
Mundipharma Research Limited1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma48
Bronchial Diseases3
Lung Diseases3
Lung Diseases, Obstructive3
Pulmonary Eosinophilia3
Respiratory Tract Diseases3
Dyspnea2
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.